AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (June 7, 2005). doi:10.1152/ajpendo.00050.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/4/E527    most recent
00050.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mackenzie, M. L
Right arrow Articles by Baracos, V. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mackenzie, M. L
Right arrow Articles by Baracos, V. E
Submitted on February 4, 2005
Accepted on May 27, 2005

A pro-inflammatory tumor that activates protein degradation sensitizes rats to catabolic effects of endotoxin

Michelle L Mackenzie1, Nathalie Bedard2, Simon S Wing2, and Vickie E Baracos3*

1 Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada
2 Polypeptide Laboratory, Department of Medicine, McGill University, Montreal, Quebec, Canada
3 Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada

* To whom correspondence should be addressed. E-mail: vickie.baracos{at}ualberta.ca.

Chronic or acute inflammation may participate in the etiology of cancer cachexia. To investigate the interaction between tumor and a secondary inflammatory stimulus on muscle wasting, rats with and without a tumor (Yoshida ascites hepatoma) received a low dose of endotoxin (LPS 400 µg/kg, s.c.) or saline. Nitrogen balance was measured 24 hours before and after LPS/saline. Epitrochlearis muscle was used to measure in vitro protein metabolism and gastrocnemius muscle was used for quantification of the mRNA for components of the ubiquitin proteolytic pathway. The Yoshida hepatoma reduced muscle mass (p=0.002), increased muscle protein degradation (p=0.042) and elevated mRNA expression of components of the ubiquitin proteolytic pathway (p<0.01) including ubiquitin, ubiquitin conjugating enzyme E214k, and ubiquitin ligases MuRF-1 and atrogin-1. Although the selected low dose of LPS had no impact on protein metabolism in control rats, LPS in rats bearing Yoshida hepatoma caused weight loss (p=0.0007), lowered nitrogen balance (p= <0.0001) and increased muscle protein degradation (p=0.0336). In conclusion, the presence of a tumor can potentiate whole body and muscle-specific catabolic losses of protein, in response to a stimulus that is not catabolic in healthy animals. This effect might be dependent on the inflammatory nature of the tumor.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.